Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03844399

(3D) Ultrasound Imaging Liver and Kidney

Use of 3-Dimensional (3D) Ultrasound Imaging to Guide the Treatment of Abdominal Tumours Using Focal Ablation or Biopsies

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Western University, Canada · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is to assess the addition of 3D ultrasound guidance during standard care ablation or biopsies of liver or kidney tumours. 3D ultrasound only differs from conventional 2D ultrasound in that the ultrasound transducer is mounted on a special assembly that moves the transducer in precise, stepped movements while a succession of 2D images are collected by the computer. Special software written specifically for 3D ultrasound precisely aligns these 2D images into a 3-demensional volume , allowing area in question to be viewed in many different planes. 3D ultrasound is a safe, fast, non-invasive imaging procedure. Ultrasound images will be checked against the pre- and post- procedure CT images to make sure the tumours were completely removed or properly targeted during biopsy.

Detailed description

Images will be acquired by a physician on patients who are undergoing a liver or kidney ablation or biopsy procedure who are well enough to provide consent. Patients will be imaged during the ablation procedure according to the standard of care, and subsequent analysis will commence following the acquisition. The devices being used are all property of the LHSC health network that have been licensed for clinical use through Health Canada. In addition, 3D ultrasound only differs from conventional 2D ultrasound in that the ultrasound transducer is mounted on a special assembly that moves the transducer in precise, stepped movements while a succession of 2D images are collected by the computer. Special software written specifically for 3D ultrasound precisely aligns these 2D images into a 3-dimensional volume, allowing the area in question to be viewed in different planes. The clinical 2D an d3D ultrasound images will be checked against the pre- and post- procedure CT images to make sure the tumours were completely removed.

Conditions

Interventions

TypeNameDescription
DEVICEAblationThe medical device will passively record image data during the standard care ablation
DEVICEBiopsyThe medical device will passively record image data during the standard care biopsy

Timeline

Start date
2020-10-03
Primary completion
2026-07-01
Completion
2027-02-01
First posted
2019-02-18
Last updated
2025-07-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03844399. Inclusion in this directory is not an endorsement.